Curcumin and neurodegenerative diseases: a perspective

Bibliography

• Duthie GG, Gardner PT, Kyle JA. Plant polyphenols: are they the new magic bullet? Proc Nutr Soc 2003;62:599-603
   PubMed Web of Science ®Google Scholar
• Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2009;2:270-8
   PubMed Web of Science ®Google Scholar
• Obrenovich ME, Nair NG, Beyaz A, The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 2010;13:631-43
   PubMed Web of Science ®Google Scholar
• Queen BL, Tollefsbol TO. Polyphenols and aging. Curr Aging Sci 2010;3:34-42
   PubMedGoogle Scholar
• Mandel S, Youdim MB. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 2004;37:304-17
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S. Resveratrol in health and disease. CRC Press Taylor & Francis Group; Boca Raton, Fl: 2006
   Google Scholar
• Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009;30:85-94
   PubMed Web of Science ®Google Scholar
• Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2009;2:409-18
   PubMed Web of Science ®Google Scholar
• Seeram NP. Emerging research supporting the positive effects of berries on human health and disease prevention. J Agric Food Chem 2012; In press
   Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009;41:40-9
   PubMed Web of Science ®Google Scholar
• Sethi G, Sung B, Aggarwal BB. The role of curcumin in modern medicine. herbal drugs: ethnomedicine to modern medicine. Springer-Verlag; Berlin, Heidelberg; 2009. p. 97-113
   Google Scholar
• Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol 2012;13:218-28
   PubMed Web of Science ®Google Scholar
• Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets 2011;12:332-47
   PubMed Web of Science ®Google Scholar
• Balasubramanian K. Molecular orbital basis for yellow curry spice curcumin's prevention of Alzheimer's disease. J Agric Food Chem 2006;54:3512-20
   PubMed Web of Science ®Google Scholar
• Esptein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010;103:1545-57
   PubMed Web of Science ®Google Scholar
• Cole GM, Yang F, Lim GP, A rationale for curcuminoids for the prevention or treatment of Alzheimer's disease. Curr Med Chem-Immun Endoc Metab Agents 2003;3:15-25
   Google Scholar
• Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Ann Indian Acad Neurol 2008;11:13-19
   PubMed Web of Science ®Google Scholar
• Sun AY, Wang Q, Simonyi A, Botanical phenolics and brain health. Neuromolecular Med 2008;10:259-74
   PubMed Web of Science ®Google Scholar
• Darvesh AS, Carroll RT, Bishayee A, Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother 2010;10:729-45
   PubMed Web of Science ®Google Scholar
• Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 2010;112:1415-30
   PubMed Web of Science ®Google Scholar
• Scapagnini G, Caruso C, Calabrese V. Therapeutic potential of dietary polyphenols against brain aging and neurodegenerative disorders. bio-farms for nutraceuticals: functional food and safety control by biosensors. Landes Bioscience and Springer Science+Business Media; Berlin, Heidelberg: 2010. p. 27-35
   Google Scholar
• Lapchak PA. Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective. Expert Opin Investig Drugs 2011;20:13-22
   PubMed Web of Science ®Google Scholar
• Kulkarni SK, Dhir A. An overview of curcumin in neurological disorders. Indian J Pharm Sci 2010;72:149-54
   PubMed Web of Science ®Google Scholar
• Bishnoi M, Chopra K, Kulkarni SK. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioral, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav 2008;88:511-22
   PubMed Web of Science ®Google Scholar
• Xu Y, Ku BS, Yao HY, The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 2005;518:40-46
   PubMed Web of Science ®Google Scholar
• Kulkarni SK, Akula KK, Deshpande J. Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. john's Wort in behavioral paradigms of despair. Pharmacology 2012;89:83-90
   PubMed Web of Science ®Google Scholar
• Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimer's Dement 2009;5:234-70
   PubMed Web of Science ®Google Scholar
• Kelsey NA, Wilkins HM, Linseman DA. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010;15:7792-814
   PubMed Web of Science ®Google Scholar
• Amor S, Puentes F, Baker D, Inflammation in neurodegenerative diseases. Immunology 2011;129:154-69
   Web of Science ®Google Scholar
• Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 2011;8:26
   PubMed Web of Science ®Google Scholar
• Rossi L, Mazzitelli S, Arciello M, Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem Res 2008;33:2390-400
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Mancuso C, Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front Biosci 2009;14:376-97
   Web of Science ®Google Scholar
• Zhao B. Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease. Neurochem Res 2009;34:630-8
   PubMed Web of Science ®Google Scholar
• Ravindran PN. Turmeric-the golden spice of life. turmeric: the genus Curcuma. Taylor and Francis Group; London; 2006. p. 1-14
   Google Scholar
• Aggarwal BB, Sundaram C, Malani N, Curcumin: the Indian solid gold. Adv Exp Med Biol 2007;595:1-75
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Bhatt ID, Ichikawa H, Curcumin-biological and medicinal properties. turmeric: the genus Curcuma. Taylor and Francis Group; London; 2006. p. 297-368
   Google Scholar
• Sarkar FH, Li Y, Wang Z, Padhye S. Lessons learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr Pharm Des 2010;16:1801-12
   PubMed Web of Science ®Google Scholar
• Geldenhuys WJ, Bishayee A, Darvesh AS, Natural products of dietary origin as lead compounds in virtual screening and drug design. Curr Pharm Biotechnol 2012;13:117-24
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807-18
   PubMed Web of Science ®Google Scholar
• Suresh D, Srinivasan K. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res 2010;131:682-91
   PubMed Web of Science ®Google Scholar
• Begum AN, Jones MR, Lim GP, Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 2008;326:196-208
   PubMed Web of Science ®Google Scholar
• Mythri RB, Bharath MS. Curcumin: a potential neuroprotective agent in Parkinson's disease. Curr Pharm Des 2012;18:91-9
   PubMed Web of Science ®Google Scholar
• Shoba G, Joy D, Joseph T, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-6
   PubMed Web of Science ®Google Scholar
• Shaikh J, Ankola DD, Beniwal V, Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009;37:395-404
   PubMedGoogle Scholar
• Mourtas S, Canovi M, Zona C, Curcumin-decorated nanoparticles with very high affinity for amyloid-beta1-42 peptide. Biomaterials 2011;32:1635-45
   PubMed Web of Science ®Google Scholar
• Taylor M, Moore S, Mourtas S, Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Abeta peptide. Nanomedicine 2011;7:541-50
   PubMed Web of Science ®Google Scholar
• Mathew A, Fukuda T, Nagaoka Y, Curcumin loaded-PGLA nanoparticles conjugated with tet-1 peptide for potential use in Alzheimer's disease. PLoS ONE 2012;7:e32616
   PubMed Web of Science ®Google Scholar
• Kumar A, Ahuja A, Ali J, Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst 2010;27:279-312
   PubMed Web of Science ®Google Scholar
• Gota VS, Maru GB, Soni TG, Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 2010;58:2095-9
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012;17:71-80
   PubMed Web of Science ®Google Scholar
• John VD, Kuttan G, Krishnakutty K. Anti-tumor studies of metal chelates of synthetic curcuminoids. J Exp Clin Cancer Res 2002;21:219-24
   PubMed Web of Science ®Google Scholar
• De Kok TM, van Breda SG, Manson MM. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 2008;47:51-9
   PubMed Web of Science ®Google Scholar
• Yang CS, Sang S, Lambert JD, Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 2008;52:139-51
   PubMed Web of Science ®Google Scholar
• Scheepens A, Tan K, Paxton JW. Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr 2010;5:75-87
   PubMed Web of Science ®Google Scholar
• Sandur SK, Pandey MK, Sung B, Curcumin, demethyoxycurcumin, bisdemethoxyxurcumin, tetrahydrocurcumin, and tumerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis 2007;8:1765-73
   Web of Science ®Google Scholar
• Khafif A, Schantz SP, Chou TC, Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 1998;19:419-24
   PubMed Web of Science ®Google Scholar
• Sharma M, Mahoharlal R, Negi AS, Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res 2010;10:570-8
   PubMed Web of Science ®Google Scholar
• Jovanovic SV, Boone CW, Steenken S, How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc 2001;123:3064-8
   PubMed Web of Science ®Google Scholar
• Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “curecumin”: from kitchen to clinic. Biochem Pharmacol 2008;75:787-809
   PubMed Web of Science ®Google Scholar
• Burgos-Morón E, Calderón-Montano JM, Salvador J, The dark side of curcumin. Int J Cancer 2010;126:1771-5
   PubMed Web of Science ®Google Scholar
• National Toxicology Program Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-1) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program 1993;427:1-275
   Google Scholar
• Kelloff GJ, Crowell JA, Steele VE, Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 2000;130:467S-71S
   PubMed Web of Science ®Google Scholar
• Strong R, Miller RA, Astle CM, Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2012; doi: 10.1093/gerona/gls070 PMID: 22451473. [Epub ahead of print]
   Web of Science ®Google Scholar
• Mancuso C, Barone E. Curcumin in clinical practice: myth or reality? Trends Pharmacol Sci 2009;30:333-4
   PubMed Web of Science ®Google Scholar
• Mancuso C, Siciliano R, Barone E. Curcumin and Alzheimer's disease: this marriage is not to be performed. J Biol Chem 2011;286:le3
   PubMedGoogle Scholar
• Bishayee A, Darvesh AS. Oxidative stress in cancer and neurodegerative diseases: prevention and treatment by dietary antioxidants. handbook of free radicals: formation, types and effects. Nova Science Publishers; Hauppauge, New York; 2010. p. 1-67
   Google Scholar
• Jayaprakasha GK, Rao LJ, Sakariah KK. Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem 2006;98:720-4
   Web of Science ®Google Scholar
• Ak T, Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008;174:27-37
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Kawakishi S, Osawa T. Involvement of the beta-diketone moiety in the antioxidant mechanism of tetrahydrocurcumin. Biochem Pharmacol 1996;52:519-25
   PubMed Web of Science ®Google Scholar
• Motterlini R, Foresti R, Bassi R, Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000;28:1303-12
   PubMed Web of Science ®Google Scholar
• Adams BK, Cai J, Armstrong J, EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 2005;16:263-75
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S, Sandur SK, Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605-21
   PubMed Web of Science ®Google Scholar
• Pan MH, Lai CS, Ho CT. Anti-inflammatory activity of natural dietary flavonoids. Food Funct 2010;1:15-31
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Ballester I, Lopez-Posadas R. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 2011;51:331-62
   PubMed Web of Science ®Google Scholar
• Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 2009;14:141-215
   PubMed Web of Science ®Google Scholar
• Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011;16:4567-98
   PubMed Web of Science ®Google Scholar
• Recio MC, Andujar I, Rios JL. Anti-inflammatory agents from plants: progress and potential. Curr Med Chem 2012; In press
   PubMedGoogle Scholar
• Gupta SC, Kim JH, Prasad H, Regulation of survival, proliferation, invasion, angiogenesis, and metastasis, of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010;29:405-34
   PubMed Web of Science ®Google Scholar
• Sethi G, Sung B, Aggarwal BB. Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 2008;233:21-31
   PubMed Web of Science ®Google Scholar
• Singh S, Aggarwal BB. Activation of transcription factor NF-kappaB is suppressed by curcumin (diferuloylmethane). J Biol Chem 1995;270:24995-5000
   PubMed Web of Science ®Google Scholar
• Sikora-Polaczek M, Bielak-Zmijewska A, Sikora E. Molecular and cellular mechanisms of curcumin action–beneficial effect on organism. Postepy Biochem 2011;57:74-84
   PubMedGoogle Scholar
• Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol 2007;595:127-48
   PubMed Web of Science ®Google Scholar
• Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 2004;68:1255-67
   PubMed Web of Science ®Google Scholar
• Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. Adv Exp Med Biol 2007;595:197-212
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006;97:1634-58
   PubMed Web of Science ®Google Scholar
• Kopec KK, Carroll RT. Phagocytosis is regulated by nitric oxide in murine microglia. Nitric Oxide 2000;4:103-11
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Reed T, Newman SF, Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007;43:658-77
   PubMed Web of Science ®Google Scholar
• Zipp F, Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 2006;29:518-27
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 2012;39:283-99
   PubMed Web of Science ®Google Scholar
• Esposito E, Cuzzocrea S. New therapeutic strategy for Parkinson's and Alzheimer's disease. Curr Med Chem 2010;17:2764-74
   PubMed Web of Science ®Google Scholar
• Song JX, Sze SC, Ng TB, Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? J Ethnopharmacol 2012;139:698-711
   PubMed Web of Science ®Google Scholar
• Craggs L, Kalaria RN. Revisiting dietary antioxidants, neurodegenration and dementia. Neuroreport 2011;22:1-3
   PubMed Web of Science ®Google Scholar
• Mancuso C, Siciliano R, Barone E, Natural substances and Alzhemier's disease: from preclinical studies to evidence based medicine. Biochim Biophys Acta 2012;1822:616-24
   PubMed Web of Science ®Google Scholar
• Ganguli M, Chandra V, Kamboh M, Apolipoprotein E polymorphism and Alzheimer's disease: the Indo-US Cross-National Dementia Study. Arch Neurol 2000;57:824-30
   PubMed Web of Science ®Google Scholar
• Chandra V, Pandav R, Dodge HH, Incidence of Alzheimer's disease in a rural community in India, the Indo-US study. Neurology 2001;57:985-9
   PubMed Web of Science ®Google Scholar
• Ng TP, Chiam PC, Lee T, Curry consumption and cognitive function in the elderly. Am J Epidemiol 2006;164:898-906
   PubMed Web of Science ®Google Scholar
• Van Marum RJ. Current and future therapy of Alzheimer's disease. Fundam Clin Pharmacol 2008;22:265-74
   PubMed Web of Science ®Google Scholar
• Pratico D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 2008;29:609-15
   PubMed Web of Science ®Google Scholar
• Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 2008;14:45-53
   PubMed Web of Science ®Google Scholar
• Ray B, Lahiri DK. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. Curr Opin Pharmacol 2009;9:434-44
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Yamada M. Curcumin and Alzheimer's disease. CNS Neurosci Ther 2010;16:285-97
   PubMed Web of Science ®Google Scholar
• Ringman JM, Frautschy SA, Cole GM, A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2005;2:131-6
   PubMedGoogle Scholar
• Frautschy SA, Cole GM. Why pleiotropic interventions are needed for Alzheimer's disease. Mol Neurobiol 2010;41:392-409
   PubMed Web of Science ®Google Scholar
• Kuner PK, Schbenel R, Hertel C. beta-Amyloid binds to p75NTR and activates NFκB in human neuroblastoma cells. J Neurosci Res 1998;54:798-804
   PubMed Web of Science ®Google Scholar
• Kim DS, Park SY, Kim JK. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA (1-42) insult. Neurosci Lett 2001;303:57-61
   PubMed Web of Science ®Google Scholar
• Ono K, Hasegawa K, Naiki H, Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 2004;75:742-50
   PubMed Web of Science ®Google Scholar
• Giri RK, Rajagopal V, Kalra VK. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 2004;91:1199-210
   PubMed Web of Science ®Google Scholar
• Yang F, Lim GP, Begum AN, Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892-01
   PubMed Web of Science ®Google Scholar
• Park SY, Kim HS, Cho EK, Curcumin protected PC12 cells against beta-amyloid-induced toxicity and inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol 2008;46:2881-7
   PubMed Web of Science ®Google Scholar
• Shytle RD, Bickford PC, Rezai-zadeh K, Optimized turmeric extracts have potent anti-amyloidogenic effects. Curr Alzheimer Res 2009;6:564-71
   PubMed Web of Science ®Google Scholar
• Guo JP, Yu S, McGeer PL. Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy. J Alzheimer's Dis 2010;19:1357-70
   Google Scholar
• Varghese K, Molnar P, Das M, A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology. PLoS ONE 2010;5:8643
   PubMed Web of Science ®Google Scholar
• Zhang C, Browne A, Child D, Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 2010;285:28472-80
   PubMed Web of Science ®Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO, ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol Pharm 2010;7:815-25
   PubMed Web of Science ®Google Scholar
• Qin XY, Cheng Y, Yu LC. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci Lett 2010;480:21-4
   PubMed Web of Science ®Google Scholar
• Liu H, Li Z, Qui D. The inhibitory effects of different curcuminoids on beta-amyloid protein, beta-amyloid precursor protein and beta-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells. Neurosci Lett 2010;485:83-8
   PubMed Web of Science ®Google Scholar
• Ahmed T, Gilani AH, Hosseinmardi N, Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices. Synapse 2011;65:572-82
   PubMed Web of Science ®Google Scholar
• Mishra S, Mishra M, Seth P. Tetrahydrocurcumin confers protection against amyloid beta-induced toxicity. Neuroreport 2011;22:23-7
   PubMed Web of Science ®Google Scholar
• Li YY, Cui JG, Hill JM, Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett 2011;487:94-8
   PubMed Web of Science ®Google Scholar
• Xiong Z, Hongmei Z, Lu S, Curcumin mediates presenilin-1 activity to reduce beta-amyloid production in a model of Alzheimer's disease. Pharmacol Rep 2011;63:1101-8
   PubMed Web of Science ®Google Scholar
• Frautschy SA, Hu W, Kim P, Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 2001;22:993-1005
   PubMed Web of Science ®Google Scholar
• Lim GP, Chu T, Yang F, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001;21:8370-7
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza M, Borelli LA, Rozkalne A, Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neuritis in an Alzheimer mouse model. J Neurochem 2007;102:1095-104
   PubMed Web of Science ®Google Scholar
• Begum AN, Jones MR, Lim GP, Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 2008;326:196-208
   PubMed Web of Science ®Google Scholar
• Pan R, Qiu S, Lu DX, Dong J. Curcumin improves learning and memory ability and its neuroprotective mechanism. Chin Med J (Engl) 2008;121:832-9
   PubMed Web of Science ®Google Scholar
• Wang YJ, Thomas P, Zhong JH, Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox Res 2009;15:3-14
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Murase A, Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 2009;175:2557-65
   PubMed Web of Science ®Google Scholar
• Ahmed T, Enam SA, Gilani AH. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Neuroscience 2010;169:1296-306
   PubMed Web of Science ®Google Scholar
• Kulkarni AP, Govender DA, Kotwal GJ, Modulation of anxiety behavior by intranasally administered vaccinia virus complement control protein and curcumin in a mouse model of Alzheimer's disease. Curr Alzheimer Res 2011;8:95-113
   PubMed Web of Science ®Google Scholar
• Kumar A, Prakash A, Dogra S. Protective effect of curcumin (Curcuma longa) against D-galactose-induced senescence in mice. J Asian Nat Prod Res 2011;13:42-55
   PubMed Web of Science ®Google Scholar
• Kakkar V, Kaur IP. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioral, biochemical and histopathological alteration in mice brain. Food Chem Toxicol 2011;49:2906-13
   PubMed Web of Science ®Google Scholar
• Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004;363:1983-93
   Google Scholar
• Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76
   PubMed Web of Science ®Google Scholar
• Mehlhornand RJ, Cole GM. The free radical theory of aging: a critical review. Adv Radical Biol Med 1985;1:165-223
   Google Scholar
• Napolitano A, Manini P, d'Ischia M. Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr Med Chem 2011;18:1832-45
   PubMed Web of Science ®Google Scholar
• Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010;37:510-18
   PubMed Web of Science ®Google Scholar
• Hong JS. Role of inflammation in the pathogenesis of Parkinson's disease: models, mechanisms, and therapeutic interventions. Ann NY Acad Sci 2005;1053:151-2
   PubMed Web of Science ®Google Scholar
• Eller M, Williams DR. alpha-Synuclein in Parkinson disease and other neurodegenerative disorders. Clin Chem Lab Med 2011;49:403-8
   PubMed Web of Science ®Google Scholar
• Chen J, Tang XQ, Zhi JL, Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 2006;11:943-53
   PubMed Web of Science ®Google Scholar
• Ono K, Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem 2006;97:105-15
   PubMed Web of Science ®Google Scholar
• Pandey N, Strider J, Nolan WC, Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol 2008;115:479-89
   PubMed Web of Science ®Google Scholar
• Wang J, Du XX, Jiang H, Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 2009;78:178-83
   PubMed Web of Science ®Google Scholar
• Ortiz-Ortiz MA, Moran JM, Ruiz-Mesa LM, Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci Lett 2010;468:120-4
   PubMed Web of Science ®Google Scholar
• Wang MS, Boddapati S, Emadi S, Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neurosci 2010;11:57
   PubMed Web of Science ®Google Scholar
• Yu S, Zheng W, Xin N, Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 2010;13:55-64
   PubMed Web of Science ®Google Scholar
• Jaisin Y, Thampithak A, Meesarapee B, Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis. Neurosci Lett 2011;489:192-6
   PubMed Web of Science ®Google Scholar
• Liu Z, Yu Y, Li X, Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Pharmacol Res 2011;63:439-44
   PubMed Web of Science ®Google Scholar
• Vajragupta O, Boonchoong P, Watanabe H, Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Radic Biol Med 2003;35:1632-44
   PubMed Web of Science ®Google Scholar
• Zbarsky V, Datla KP, Parkar S, Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005;39:1119-25
   PubMed Web of Science ®Google Scholar
• Rajeswari A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur Rev Med Pharmacol Sci 2006;10:157-61
   PubMedGoogle Scholar
• Rajeswari A, Sabesan M. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 2008;16:96-9
   PubMedGoogle Scholar
• Mythri RB, Veena J, Harish G, Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: implications for Parkinson's disease. Br J Nutr 2011;106:63-72
   PubMed Web of Science ®Google Scholar
• Mansouri Z, Sabetkasaei M, Moradi F, Curcumin has neuroprotection effect on homocysteine rat model of Parkinson. J Mol Neurosci 2012; In press
   PubMed Web of Science ®Google Scholar
• Tripanichkul W, Jaroensuppaperch EO. Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. Int J Neurosci 2012; In press
   PubMed Web of Science ®Google Scholar
• Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009;14:226-46
   PubMed Web of Science ®Google Scholar
• Perez-Jimenez J, Serrano J, Tabernero M, Bioavailability of phenolic antioxidants associated with dietary fiber: plasma antioxidant capacity after acute and long-term intake in humans. Plant Foods Hum Nutr 2009;64:102-7
   PubMed Web of Science ®Google Scholar
• Belkacemi A, Doggui S, Dao L, Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev Mol Med 2011;13:e34
   PubMed Web of Science ®Google Scholar
• Baum L, Lam CW, Cheung SK, Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 2008;28:110-13
   PubMed Web of Science ®Google Scholar
• Thomas-Eapen NE. Turmeric: the intriguing yellow spice with medicine properties. Explore (NY) 2009;5:114-15
   PubMedGoogle Scholar
• Shen L, Ji H-F. The pharmacology of curcumin: is it the degradation products? Trends Mol Med 2012;18:138-44
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007;40:92-100
   PubMed Web of Science ®Google Scholar
• Makni M, Chtourou Y, Fetoui H, Evaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats. Eur J Pharmacol 2011;668:133-9
   PubMed Web of Science ®Google Scholar
• Yan JJ, Cho JY, Kim HS, Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 2001;133:89-96
   PubMed Web of Science ®Google Scholar
• Ono K, Hirohata M, Yamada M. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro. Biochem Biophys Res Commun 2005;336:444-9
   PubMed Web of Science ®Google Scholar
• Thomas P, Wang YJ, Zhong JH, Grape seed polyphenols and curcumin reduce genomic instability events reduce genomic instability events in a transgenic mouse model for Alzheimer's disease. Mutat Res 2009;661:25-34
   PubMed Web of Science ®Google Scholar